Reckitt Benckiser Group (RBGLY)
(Delayed Data from OTC)
$10.92 USD
-0.06 (-0.55%)
Updated Apr 25, 2024 11:07 AM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Reckitt Benckiser Group PLC (RBGLY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$12.50 | $12.50 | $12.50 | 13.84% |
Price Target
Only one analyst offered a short-term price target of $12.50 for Reckitt Benckiser Group PLC. This represents an increase of 13.84% from the last closing price of $10.98.
Analyst Price Targets (1 )
Broker Rating
Reckitt Benckiser Group PLC currently has an average brokerage recommendation (ABR) of 2.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.75 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 37.5% and 12.5% of all recommendations. A month ago, Strong Buy made up 25%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.38 | 2.75 | 2.75 | 2.75 | 2.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/27/2023 | Berenberg Bank | Fulvio Cazzol | Not Available | Hold |
9/12/2023 | Exane BNP Paribas | Jeffrey P Stent | Not Available | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.38 |
ABR (Last week) | 2.75 |
# of Recs in ABR | 8 |
Average Target Price | $12.50 |
LT Growth Rate | 6.40% |
Industry | Soap and Cleaning Materials |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | NA |